BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34239928)

  • 1. Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
    Song F; Zhang K; Huang J; Qian Z; Zhou H; Cai J; Zheng C; Zhou F; Cui W; Zhang G
    Biomed Res Int; 2021; 2021():6619911. PubMed ID: 34239928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.
    Cristina ML; Alicino C; Sartini M; Faccio V; Spagnolo AM; Bono VD; Cassola G; De Mite AM; Crisalli MP; Ottria G; Schinca E; Pinto GL; Bottaro LC; Viscoli C; Orsi A; Giacobbe DR; Icardi G;
    J Infect Public Health; 2018; 11(2):171-177. PubMed ID: 28668656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
    Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
    BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy.
    Alicino C; Giacobbe DR; Orsi A; Tassinari F; Trucchi C; Sarteschi G; Copello F; Del Bono V; Viscoli C; Icardi G
    BMC Infect Dis; 2015 Oct; 15():415. PubMed ID: 26464061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.
    Giannella M; Trecarichi EM; De Rosa FG; Del Bono V; Bassetti M; Lewis RE; Losito AR; Corcione S; Saffioti C; Bartoletti M; Maiuro G; Cardellino CS; Tedeschi S; Cauda R; Viscoli C; Viale P; Tumbarello M
    Clin Microbiol Infect; 2014 Dec; 20(12):1357-62. PubMed ID: 24980276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
    Chen Y; Chen Y; Liu P; Guo P; Wu Z; Peng Y; Deng J; Kong Y; Cui Y; Liao K; Huang B
    BMC Geriatr; 2022 Jul; 22(1):573. PubMed ID: 35831805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
    Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
    Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymicrobial bloodstream infections a risk factor for mortality in neonates at the national hospital, Tanzania: A case-control study.
    Manyahi J; Joachim A; Msafiri F; Migiro M; Mwingwa A; Kasubi M; Naburi H; Majigo MV
    PLoS One; 2024; 19(4):e0302076. PubMed ID: 38625965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019.
    Li M; Yang S; Yao H; Liu Y; Du M
    Infect Dis Ther; 2023 Feb; 12(2):473-485. PubMed ID: 36520329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-Resistant
    Chen Q; Zheng Z; Shi Q; Wu H; Li Y; Zheng C
    Can J Infect Dis Med Microbiol; 2022; 2022():8368578. PubMed ID: 35783362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for and Clinical Outcomes of Polymicrobial
    Qian Z; Zhang S; Li N; Ma W; Zhang K; Song F; Zheng C; Zhong L; Wang Y; Cai J; Zhou H; Cui W; Zhang G
    Biomed Res Int; 2022; 2022():5122085. PubMed ID: 35265714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.